Laboratory Corporation of America Holdings operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Laboratory Corporation of America Holdings with three other
pharmaceutical manufacturers in North America:
sales of $13.45 billion
of which 81%
was Product revenues, net),
Bausch Health Companies Inc
(10.89 billion Canadian Dollars [US$8.26 billion]
of which 56%
was Bausch + Lomb / International segment), and
of which 37%
was North America).
During the year ended December of 2018, sales at
Laboratory Corporation of America Holdings were $11.33 billion.
increase of 11.0%
versus 2017, when the company's sales were $10.21 billion.
This was the fifth consecutive year of sales increases at Laboratory Corporation of America Holdings
(and since 2013, sales have increased a total of 95%).
Sales of Cdd saw an increase
that was more than double the company's growth rate: sales were up
42.0% in 2018, from
$3.04 billion to $4.31 billion.
Not all segments of Laboratory Corporation of America Holdings experienced an increase in sales in 2018:
sales of Lcd fell 1.9% to $7.03 billion.